Venipuncture Needle and Syringes Market By Type (Venipuncture Needles, Syringes), By Material (Stainless Steel, Plastic, Glass), By Needle Size (Small Needles (28G to 30G), Medium Needles (21G to 27G), Large Needles (16G to 20G)), By End-User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Venipuncture Needle and Syringes Market was valued at USD 3.1 billion in 2024-e and will surpass USD 4.9 billion by 2030; growing at a CAGR of 8.0% during 2025 - 2030.

The global Venipuncture Needle and Syringes market is crucial for the healthcare industry, driven by the increasing demand for safe, efficient, and precise medical devices. Venipuncture needles and syringes are essential tools used in procedures like blood collection, injections, and various therapeutic treatments. These devices play a critical role in patient care, and advancements in their design and functionality have contributed to better medical outcomes and enhanced safety standards.

The market is experiencing steady growth, fueled by the rise in chronic diseases, an aging population, and the increasing number of medical procedures that require venipuncture. Additionally, the global focus on patient safety and the shift toward minimally invasive treatments are contributing to the growing adoption of high-quality and innovative needle and syringe solutions.

Venipuncture Needles Lead the Market Owing to Widespread Use in Medical Applications

Venipuncture Needles are the largest segment in the market due to their widespread use in various medical applications, including blood draws, injections, and intravenous therapies. Venipuncture needles come in various sizes to cater to different patient needs and medical procedures. The demand for these needles is primarily driven by the need for more efficient, minimally invasive, and safe solutions in healthcare settings.

The rise in outpatient services and ambulatory care centers, along with the increasing number of procedures requiring venipuncture, is further propelling the demand for these needles. Hospitals, clinics, and healthcare institutions are increasingly adopting high-quality venipuncture needles to improve patient care, reduce complications, and enhance the overall efficiency of medical procedures.

Medium Needles Hold Significant Market Share Owing to Versatility and Comfort

Medium Needles (21G to 27G) are expected to hold a significant share of the market due to their versatility and wide application range. These needles are commonly used for blood draws, intravenous injections, and other clinical procedures, offering a balance between comfort, efficiency, and precision. Medium-sized needles are favored in most clinical settings for their ability to accommodate a variety of injection volumes while minimizing discomfort to the patient.

As the healthcare industry increasingly focuses on patient comfort and safety, medium needles are becoming the preferred choice for many medical professionals. Their widespread use in hospitals, clinics, and other healthcare settings continues to drive demand for this segment, contributing to overall market growth.

Stainless Steel Remains the Dominant Material Owing to Durability and Sterilization Ease

Stainless Steel is the dominant material in the production of venipuncture needles and syringes due to its strength, durability, and resistance to corrosion. Stainless steel is preferred for its sharpness, which ensures more precise and less painful insertions. It also maintains its integrity during medical procedures, which is essential for patient safety.

Additionally, the growing focus on reducing healthcare-associated infections has further cemented stainless steel's position in the market. The material's ability to be easily sterilized and its compatibility with single-use and disposable medical devices contribute to its widespread adoption in the industry.

End-User Segment Drives Market Expansion Owing to Growing Healthcare Facilities and Home Healthcare Trends

Hospitals, clinics, and ambulatory surgical centers are the leading end-users of venipuncture needles and syringes. These healthcare settings account for the largest share of the market due to the high volume of medical procedures performed, including blood draws, injections, and intravenous therapies. The increasing patient population and the rising demand for quality healthcare are contributing to the continued expansion of these facilities, directly boosting the demand for venipuncture devices.

Home healthcare, on the other hand, is gaining traction as patients seek more comfortable and convenient ways to receive medical treatments. The demand for home healthcare services, driven by chronic disease management and aging populations, is contributing to the increasing adoption of venipuncture needles and syringes for at-home blood collection and infusion therapies.

North America Leads Due to High Healthcare Expenditure and Technological Advancements

North America holds the largest share of the venipuncture needle and syringes market, driven by the region's advanced healthcare infrastructure and high demand for medical procedures that require venipuncture, such as blood collection and intravenous treatments. The United States, with its high healthcare spending and well-established medical device market, contributes significantly to the region’s dominance. Furthermore, technological advancements in needle and syringe designs, aimed at improving patient comfort and safety, have led to increased adoption.

The increasing prevalence of chronic diseases, including diabetes and cardiovascular conditions, has further fueled the demand for venipuncture devices in North America. Moreover, healthcare facilities in the region are adopting advanced disposable devices to ensure patient safety and minimize the risk of infections, thereby boosting market growth.

Leading Companies and Competitive Landscape

The Venipuncture Needle and Syringes market is highly competitive, with leading players such as Becton, Dickinson and Company (BD), Terumo Corporation, and Smiths Medical driving innovation and growth. These companies focus on developing advanced products that meet the evolving needs of healthcare professionals and patients. To maintain their competitive edge, players in the market are investing heavily in research and development to enhance the safety, comfort, and efficiency of their needle and syringe solutions.

As the market continues to grow, these companies are expanding their product portfolios and focusing on key trends such as safety features (e.g., retractable needles), environmentally friendly materials, and the increasing demand for home healthcare solutions. Additionally, partnerships, acquisitions, and collaborations are common strategies employed by market leaders to strengthen their position in the market and drive further innovation.

Recent Developments:

• In March 2025, Becton, Dickinson and Company (BD) launched a new line of safety syringes designed to reduce the risk of needlestick injuries. The product launch is expected to strengthen BD’s position in the safety medical devices market.
• In February 2025, Medtronic plc announced the expansion of its hypodermic needle production facility in Europe to meet the growing demand for diabetes care products. This move is aimed at enhancing its market reach in the diabetic care segment.
• In January 2025, Terumo Corporation unveiled a new range of retractable syringes to enhance safety in healthcare settings. This innovation is part of their ongoing effort to reduce needle-related injuries in hospitals.
• In December 2024, Smiths Medical acquired a leading syringe manufacturer to enhance its global portfolio of injectable products. The acquisition is expected to strengthen Smiths Medical's product offerings in the critical care space.
• In November 2024, Cardinal Health announced a partnership with a major healthcare provider to distribute pre-filled syringes for oncology treatments. This collaboration is aimed at improving patient care by offering convenient, ready-to-use syringes for cancer treatments.

List of Leading Companies:

• Becton, Dickinson and Company (BD)
• Medtronic plc
• Terumo Corporation
• Smiths Medical
• Cardinal Health, Inc.
• Nipro Corporation
• Stryker Corporation
• Braun Melsungen AG
• Teleflex Incorporated
• Edwards Lifesciences Corporation
• Cook Medical
• Johnson & Johnson
• Vygon
• Halyard Health (now part of Owens & Minor)
• Shanghai Jinhuan Medical Instruments Co., Ltd.

Report Scope: